CDKN1C
Cyclin-dependent kinase inhibitor 1C
Also known as: BWCR, BWS, CDN1C_HUMAN, KIP2, P57
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49918
- Gene
- CDKN1C
- Ensembl
- ENSG00000129757
- Chromosome
- 11
- Canonical length
- 316 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
316 residues, UniProt reviewed canonical sequence.
>P49918|CDKN1C
1 MSDASLRSTS TMERLVARGT FPVLVRTSAC RSLFGPVDHE ELSRELQARL AELNAEDQNR
61 WDYDFQQDMP LRGPGRLQWT EVDSDSVPAF YRETVQVGRC RLLLAPRPVA VAVAVSPPLE
121 PAAESLDGLE EAPEQLPSVP VPAPASTPPP VPVLAPAPAP APAPVAAPVA APVAVAVLAP
181 APAPAPAPAP APAPVAAPAP APAPAPAPAP APAPAPDAAP QESAEQGANQ GQRGQEPLAD
241 QLHSGISGRP AAGTAAASAN GAAIKKLSGP LISDFFAKRK RSAPEKSSGD VPAPCPSPSA
301 APGVGSVEQT PRKRLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDKN1C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 192 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 192 nTPM
- ovary: 188 nTPM
- adrenal gland: 171 nTPM
- kidney: 136 nTPM
- adipose tissue: 114 nTPM
- breast: 85 nTPM
Single-cell type
- syncytiotrophoblasts: 618 nCPM
- podocytes: 513 nCPM
- extravillous trophoblasts: 506 nCPM
- late spermatids: 234 nCPM
- early spermatids: 148 nCPM
- cytotrophoblasts: 147 nCPM
Immune cell
- non-classical monocyte: 288 nTPM
- intermediate monocyte: 118 nTPM
- myeloid DC: 23 nTPM
- total PBMC: 13 nTPM
- basophil: 8.1 nTPM
- neutrophil: 1.8 nTPM
Brain region
- white matter: 211 nTPM
- medulla oblongata: 130 nTPM
- cerebellum: 105 nTPM
- pons: 99 nTPM
- basal ganglia: 91 nTPM
- thalamus: 86 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDKN1C.
Disease | AllUniProt
Conditions CDKN1C is implicated in, by any mechanism.
- Beckwith-Wiedemann syndrome (BWS) MIM:130650
- Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies (IMAGE) MIM:614732
Disease | GeneticClinVar
128 pathogenic / likely-pathogenic of 1,279 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Beckwith-Wiedemann syndrome
- IMAGe syndrome
- CDKN1C-related disorder
- Inborn genetic diseases
- Silver-Russell syndrome 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 1.93
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenal gland development
- camera-type eye development
- digestive system development
- embryonic placenta morphogenesis
- genomic imprinting
- kidney development
- multicellular organism growth
- myeloid cell differentiation
- negative regulation of epithelial cell proliferation
- negative regulation of mitotic cell cycle
- negative regulation of transcription by RNA polymerase II
- neuron maturation
- positive regulation of transforming growth factor beta receptor signaling pathway
- regulation of exit from mitosis
- regulation of lens fiber cell differentiation
- skeletal system development
- uterus development
Molecular functions
- cyclin-dependent protein serine/threonine kinase inhibitor activity
- molecular function inhibitor activity
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDKN1C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDKN1C as an antibody target. Whether an autoantibody or antibody against CDKN1C could matter depends on whether native CDKN1C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDKN1C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDKN1C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...